Gene · 3021
Papers1,611
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,611
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring Molecular Pathways in Metastasis of Breast Cancer Cells to the Brain: Insights from Gene Expression Analysis and Cellular Origins. | J Microsc Ultrastruct | 2026 | 42824931 | PubTator, text mining | PubMed |
| H3F3B gene mutation in chondroblastomas: a multicenter study. | Acta Orthop Traumatol Turc | 2026 | 42813348 | PubTator, text mining | PubMed |
| Exon-skipping antisense oligonucleotides for H3.3K27M-altered diffuse midline glioma therapy. | Mol Ther Nucleic Acids | 2026 | 42656813 | PubTator, text mining | PubMed |
| Stepwise Protocol for Alternative Splicing Analysis in Single-Cell SMART-Seq2 RNA-Seq Data. | Bio Protoc | 2026 | 42367213 | PubTator, text mining | PubMed |
| Clarification of the published survival analysis in H3F3B p.K27I-mutant diffuse midline glioma. | Acta Neuropathol Commun | 2026 | 42321911 | PubTator, text mining | PubMed |
| Defective plasticity in dermatomyositis patients muscle stem cells is associated with sustained intrinsic inflammatory signaling and disruption of the histone H3.3 chromatin loading pathway. | NAR Mol Med | 2026 | 42199921 | PubTator, text mining | PubMed |
| Impact of Chromosomal Instability and Aneuploidy in Cancer Development. | Annu Rev Cancer Biol | 2026 | 42137044 | PubTator, text mining | PubMed |
| Uterine fluid extracellular vesicle miR-223-3p as endometrial receptivity biomarker and regulator in implantation. | Reproduction | 2026 | 42118112 | PubTator, text mining | PubMed |
| Evidence for coordinate CTCF and histone H3.3 activities in K27M diffuse midline gliomas. | Acta Neuropathol Commun | 2026 | 42070015 | PubTator, text mining | PubMed |
| In silico analysis of gene expression signatures and drug repurposing associated with metastatic progression in melanoma (skin cancer). | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 42068380 | PubTator, text mining | PubMed |
| HIRA-SETDB1-H3K9me3 axis regulates chromatin architecture in leukemia cells. | J Biol Chem | 2026 | 42055326 | PubTator, text mining | PubMed |
| Impact of Genetic Mutations on Response and Time to Progression after Radioembolization of Breast Cancer Liver Metastases. | J Vasc Interv Radiol | 2026 | 42025916 | PubTator, text mining | PubMed |
| ATRX loss in sarcomas is associated with dysregulated gene and transposable element expression, loss of DNA methylation, and worse survival. | ESMO Rare Cancers | 2026 | 41994103 | PubTator, text mining | PubMed |
| Non-canonical histone H3.3 and its chaperones HIRA and DAXX participate in the regulation of KSHV latency. | bioRxiv | 2026 | 41993451 | PubTator, text mining | PubMed |
"Targeting NF-κB epigenetic activation and DNA repair deficiency in G34-mutant pediatric diffuse hemispheric glioma with nanoparticles combining PARP inhibition and immune stimulation mediated by CpG dinucleotides". | bioRxiv | 2026 | 41959143 | PubTator, text mining | PubMed |
| Exon-Skipping Antisense Oligonucleotides for H3.3K27M-Altered Diffuse Midline Glioma Therapy. | bioRxiv | 2026 | 41959111 | PubTator, text mining | PubMed |
| Presence of IDH2 and TP53 mutations significantly reduces survival of patients with chondrosarcoma. | Cancer | 2026 | 41906217 | PubTator, text mining | PubMed |
| Distinct DAXX effector modules separate H3.3 nucleosome assembly from ERV silencing. | bioRxiv | 2026 | 41877993 | PubTator, text mining | PubMed |
| Cohesin prevents local mixing of condensed euchromatic domains in living human cells. | bioRxiv | 2026 | 41867868 | PubTator, text mining | PubMed |
| Acetylation of H3K115 is associated with fragile nucleosomes at CpG island promoters and active regulatory sites. | Elife | 2026 | 41778583 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3021/papers